Codelivery of BCL2 and MCL1 Inhibitors Enabled by Phenylboronic Acid‐Functionalized Polypeptide Nanovehicles for Synergetic and Potent Therapy of Acute Myeloid Leukemia

Abstract Acute myeloid leukemia (AML) is the most refractory hematologic malignancy characterized by acute onset, rapid progression, and high recurrence rate. Here, codelivery of BCL2 (ABT199) and MCL1 (TW37) inhibitors using phenylboronic acid‐functionalized polypeptide nanovehicles to achieve syne...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jiguo Xie, Xiaofei Zhao, Peng Zhang, Yueyue Zhang, Ru Cheng, Zhiyuan Zhong, Chao Deng
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2023-03-01
Ráidu:	Advanced Science
Fáttát:	acute myeloid leukemia BCL2 inhibitor BN coordination boronic ester bond MCL1 inhibitor synergetic therapy
Liŋkkat:	https://doi.org/10.1002/advs.202204866
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!